- Supported exchanges /
- F /
- DTC.F
Defence Therapeutics Inc. (DTC F) stock market data APIs
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology, including antibody drug conjugates targeting various cancers; anti-cancer AccuTOX program, which has completed preclinical studies for solid T-cell lymphoma, breast cancer, and melanoma; ARM-X vaccine program, a mesenchymal stem cell-based vaccine targeting cancer; and mRNA vaccination program. It also offers Accuvac for dendritic cell cancer vaccines; a protein-based vaccine formulation against COVID and infectious diseases; and cervical cancer vaccine. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Defence Therapeutics Inc. Financial Data Overview
| 0.438 | |
| 0.36 | |
| - | |
| 0.438 | |
| 0.36 | |
| 0.32-1.985 | |
| 16 512 K | |
| 45 537 K | |
| 0 | |
| 1.445 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Defence Therapeutics Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -12 675 782
- Earnings Per Share -0.2
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Defence Therapeutics Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Defence Therapeutics Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
